Sigyn Therapeutics, Inc. (SIGY) stock
SIGYOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $48.16KP/E –Yield –
Sigyn Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Sigyn Therapeutics's operating margin for the twelve months ending Sep 30, 2020 was -7019.1%. For fiscal 2019 it was -361.4%, against -3544.2% the year before. The highest annual figure on record is -361.4% in fiscal 2019.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | -361.4% | +3182.8 |
| FY2018 | Dec 31, 2018 | -3544.2% | +1733.2 |
| FY2017 | Dec 31, 2017 | -5277.4% | +2436.9 |
| FY2015 | Dec 31, 2015 | -7714.3% | −6816.3 |
| FY2014 | Dec 31, 2014 | -898.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2020 | Sep 30, 2020 | -5294.1% | −5136.6 |
| Q1 FY2020 | Mar 31, 2020 | -25526.3% | −25120.0 |
| Q4 FY2019 | Dec 31, 2019 | -2342.4% | −2075.6 |
| Q3 FY2019 | Sep 30, 2019 | -382.3% | +3657.3 |
| Q2 FY2019 | Jun 30, 2019 | -157.5% | +1087.6 |
| Q1 FY2019 | Mar 31, 2019 | -406.4% | −179.7 |
| Q3 FY2018 | Sep 30, 2018 | -266.8% | −124.5 |
| Q2 FY2018 | Jun 30, 2018 | -4039.6% | −3911.6 |
| Q1 FY2018 | Mar 31, 2018 | -1245.1% | – |
| Q3 FY2017 | Sep 30, 2017 | -226.7% | – |
| Q2 FY2017 | Jun 30, 2017 | -142.3% | – |
| Q1 FY2017 | Mar 31, 2017 | -128.0% | – |
See a number that looks wrong?